Squarepoint
MBIO icon

Squarepoint’s Mustang Bio MBIO Stock Holding History

Squarepoint’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-299
Closed -$15.5K – 4420
2024
Q1 		$15.5K Buy
+299
New +$19K ﹤0.01% 3933
2021
Q3 		– Sell
-25
Closed -$61K – 3214
2021
Q2 		$61K Buy
+25
New +$61.3K ﹤0.01% 3086
2021
Q1 		– Sell
-339
Closed -$961K – 3410
2020
Q4 		$961K Buy
339
+182
+116% +$435K 0.01% 1361
2020
Q3 		$370K Buy
157
+88
+128% +$217K 0.01% 1646
2020
Q2 		$164K Sell
69
-25
-27% -$58.5K ﹤0.01% 1885
2020
Q1 		$190K Buy
+94
New +$241K ﹤0.01% 1492
2018
Q3 		– Sell
-16
Closed -$81K – 2111
2018
Q2 		$81K Buy
+16
New +$101K ﹤0.01% 1660

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Squarepoint's MBIO Position: Q2 2024 in Review

Squarepoint sold out of Mustang Bio (MBIO) in Q2 2024, closing a stake of 299 shares — an estimated $15.5K sold.

Squarepoint first reported a position in MBIO in Q2 2018 and held it in 7 quarters. The position peaked at $961K in Q4 2020. 28 funds tracked by Wall St. Rank hold MBIO as of Q2 2024.

  • Squarepoint reported no remaining Mustang Bio position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 299 Mustang Bio shares in Q2 2024, an estimated $15.5K.
  • Squarepoint first reported a position in Mustang Bio in Q2 2018 and held it in 7 quarters.
  • Squarepoint's Mustang Bio position peaked at $961K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.